Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Keep An Eye On Harmful UV Rays
Ultraviolet (UV) radiation is a concern for many Americans, but most people are thinking about protecting their skin, not their eyes. Whether it"s a cloudy or sunny day, summer or winter, the American Optometric Association (AOA) reminds Americans to take specific measures to protect their eyes from the sun"s UV rays in order to decrease the risk of vision disorders.
generic viagra online
Pfizer Discontinues Phase 3 Trial Of Sutent(R) In Metastatic Colorectal Cancer
Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent® (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment of metastatic colorectal cancer (CRC). The independent Data Monitoring Committee (DMC) found that the addition of sunitinib to the chemotherapy regimen FOLFIRI would be unable to demonstrate a statistically significant improvement in the primary endpoint of progression-free survival (PFS) compared to FOLFIRI alone, in this study. No new safety issues were identified.
News of the day
Removal Of Tonsils And Adenoids Associated With Ongoing Benefits For Children With Breathing Problems During Sleep
Two and a half years after children with sleep-related breathing disorders had surgery to remove their tonsils and adenoids (glands in the back of the throat), they appear to sleep better than they did before the procedure but not as well as they did six months after, according to a report in the July issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Initial improvements in their behavior were maintained except when measured by an index of attention-deficit/hyperactivity disorder (ADHD) symptoms.
Medical Devices

Pharmacies Urged To Register From 1 - 31 July 2009 To Receive Early-bird Payment

Community pharmacies are urged to register to participate in Phase 2 of the Dose Administration Aids (DAA) and Patient Medication Profile (PMP) programs. Pharmacies registering from 1 to 31 July 2009 will be eligible for the full incentive payment of $2,250 for DAA and $1,250 for PMP (+GST). While registrations will still be accepted after July, a lesser incentive payment will apply. "We need as many pharmacies as possible to participate in Phase 2 of these programs to ensure the ongoing and sustainable delivery of these important services," said Mr Kos Sclavos, .National President of the Pharmacy Guild of Australia. In response to feedback from community pharmacy, the DAA and PMP programs, managed by the Pharmacy Guild of Australia, have been reviewed and revamped to make participation in them easier and systems more user-friendly. The amount of time and data required has been reduced, and the payment deadlines have been simplified. "DAA and PMP services offer clear benefits to patients and the wider community. Patients have better medication management, and better continuity of care. The community have fewer hospitalizations associated with medicine misadventure and delayed admissions to aged care services," said Mr Warwick Plunkett, National President of the Pharmaceutical Society of Australia. Medication misadventure is estimated to cost the health sector $380 million a year ( "Improving Medication Safety" by the Australian Council for Safety and Quality in Healthcare, 2002). The DAA program allows pharmacist to organise patients" medicines into weekly blister packs. The PMP allows pharmacists to produce a comprehensive profile of the patient"s medicines, including information about instructions for use, appearance and generic substitution availability. The DAA and PMP Programs are funded under the Better Community Health Initiative of the Fourth Community Pharmacy Agreement by the Australian Government Department of Health and Ageing. In mid-June, all pharmacies will receive a new Pharmacy Readiness Kit with information and new PMP promotional materials to support their participation. For more information visit the Guild website at http://www.guild.org.au Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009